PRZOOM - /newswire/ -
Philadelphia, PA, United States, 2009/03/30 - Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm is pleased to announce the addition of new management team member, Bill Baxter.
CIS is excited to have Mr. Baxter, a proven professional who will help guide the company’s continued growth, specifically in the Government Programs area.
Bill Baxter has over 38 years diverse pharmaceutical industry experience including Medicaid Contracting, Government Affairs, Sales, Sales Management, and Training. Prior to his work at Johnson & Johnson, he taught social studies in the St. Louis School System.
“Many in the industry know Bill’s work with the numerous federal and state programs and his vast experience and knowledge in the Medicaid market,” said Chris Cobourn, VP Regulatory Compliance and Practice Lead.
“His expertise will be a valuable asset to CIS. This is especially true now with so many changes and increased scrutiny at both the Federal and State levels. Bill has been involved in Medicaid and other programs since their beginning. His well rounded understanding of the programs, including the agencies, the regulations, and the operational and organizational impact at the manufacturer, brings a unique perspective that will be a great compliment to our current staff of GP consultants, and we are very excited to have him join the CIS family.”
Bill formerly held the position of Chairman of State Health Care Policy Council, an organization tasked with providing a forum for J&J operating company management to review emerging health care issues and developing policy. He was also a participating member of J&J Medicaid and Medicare Task Forces.
CIS (cis-partners.com) is a pharmaceutical compliance consulting firm specializing in establishing a "Culture of Compliance" by providing a deep understanding of industry laws and regulations, innovative and practical approaches and fit-for-purpose solutions. CIS consultants understand and specialize in interpreting and implementing legal and regulatory requirements that have the greatest impact on research, development and commercial activities. This allows clients to proactively manage risk through identification and integration of appropriate compliance strategies.